Jun 2026 (Q2 FY26) — Aug 11, 2026
Ambiq Micro Q2 FY26 — Edge AI Demand Drives Strong Growth Amidst Supply Constraints
Read the full callAmbiq Micro (AMBQ) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Ambiq Micro earnings: last reported Tue, 11 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 33.9 | +89.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -25.7 | +23.5 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -7.1 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$49.62 −0.52% · −$0.26
Performance +63.4% 1Y
1Y: $30.36 on 17 Oct 2025 → $49.62. High $90.48 (18 Jun 2026), low $22.76 (20 Nov 2025).
- Previous close
- $49.88
- 52-week range
- $22.76 – $90.48
- One year
- +56.14%
Overview
- Symbol
- AMBQ
- Sector
- Information Technology
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Ambiq Micro earnings calls (AMBQ)
Financials
What the filings say
Net profit, year on year: +16% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 20 | 20 | 16 | 18 | 18 | 21 | 25 | 34 |
| Operating profit | -10 | -10 | -9 | -9 | -10 | -12 | -12 | -9 |
| Operating margin | −49.8% | −51.0% | −55.6% | −49.2% | −55.3% | −57.7% | −46.6% | −25.7% |
| Profit before tax | -9 | -10 | -8 | -8 | -9 | -11 | -10 | -7 |
| Tax rate | −0.1% | −0.0% | −0.1% | −0.2% | −0.0% | −0.2% | −0.0% | −0.0% |
| Net profit | -9 | -10 | -8 | -8 | -9 | -11 | -10 | -7 |
| EPS ($ per share) | -26.03 | — | -18.96 | -18.89 | -0.72 | — | -0.50 | -0.32 |
| Line item | Dec 2024 | Dec 2025 |
|---|---|---|
| Equity capital | 0 | 0 |
| Reserves | -320 | -357 |
| Total liabilities | 19 | 22 |
| Fixed assets | 3 | 4 |
| Total assets | 104 | 185 |
| Line item | Dec 2024 | Dec 2025 |
|---|---|---|
| Cash from operations | -21 | -20 |
| Cash from investing | -4 | -7 |
| Cash from financing | 59 | 106 |
| Net cash flow | 34 | 79 |
Insider filings
119 filings between Jan 5, 2026 and Oct 15, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$38.93M
79 sales by 8 insiders
61% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 12
- Award — granted as compensation
- 28
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Esaka Fumihide | — | $16.63M | Oct 15, 2026 |
| Chen Sean Chihhsiang | — | $7.43M | Oct 14, 2026 |
| Hanson Scott McLean | — | $6.13M | Oct 15, 2026 |
| Chen Timothy | — | $5.63M | May 27, 2026 |
| Winzeler Jeffrey G | — | $2.20M | Oct 2, 2026 |
| ZHANG KER | — | $644.9K | Sep 11, 2026 |
| TAUTGES JOSEPH A | — | $241.8K | Jan 26, 2026 |
| Connors Michele Kim | — | $21.2K | Apr 2, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2026 | Esaka Fumihide Chief Executive Officer | Sale 10b5-1 plan | 500 | $24.6K |
| Oct 15, 2026 | Hanson Scott McLean Chief Technology Officer | Sale 10b5-1 plan | 1,800 | $93.4K |
| Oct 15, 2026 | Esaka Fumihide Chief Executive Officer | Sale 10b5-1 plan | 500 | $25.0K |
| Oct 15, 2026 | Hanson Scott McLean Chief Technology Officer | Sale 10b5-1 plan | 900 | $45.1K |
| Oct 15, 2026 | Esaka Fumihide Chief Executive Officer | Option exercise 10b5-1 plan | 5,000 | $40.6K |
| Oct 15, 2026 | Hanson Scott McLean Chief Technology Officer | Sale 10b5-1 plan | 3,700 | $189.1K |
| Oct 15, 2026 | Esaka Fumihide Chief Executive Officer | Sale 10b5-1 plan | 2,800 | $143.2K |
| Oct 15, 2026 | Esaka Fumihide Chief Executive Officer | Sale 10b5-1 plan | 1,200 | $62.2K |
| Oct 15, 2026 | Hanson Scott McLean Chief Technology Officer | Option exercise 10b5-1 plan | 7,000 | $56.8K |
| Oct 15, 2026 | Hanson Scott McLean Chief Technology Officer | Sale 10b5-1 plan | 600 | $29.4K |
| Oct 14, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 200 | $10.9K |
| Oct 14, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 2,000 | $104.9K |
| Oct 14, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 7,539 | $377.9K |
| Oct 14, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 4,000 | $213.7K |
| Oct 14, 2026 | Chen Sean Chihhsiang President and COO | Option exercise 10b5-1 plan | 15,000 | $121.8K |
| Oct 14, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 1,261 | $65.0K |
| Oct 5, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 1,797 | $120.9K |
| Oct 5, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 800 | $54.5K |
| Oct 5, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 100 | $7.0K |
| Oct 5, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 5,508 | $365.6K |
| Oct 2, 2026 | Esaka Fumihide Chief Executive Officer | Sale | 7,113 | $491.6K |
| Oct 2, 2026 | Hanson Scott McLean Chief Technology Officer | Sale | 4,500 | $314.0K |
| Oct 2, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 3,008 | $209.9K |
| Oct 2, 2026 | Hanson Scott McLean Chief Technology Officer | Sale | 452 | $32.5K |
| Oct 2, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 2,492 | $172.2K |
| Oct 2, 2026 | Esaka Fumihide Chief Executive Officer | Sale | 8,585 | $599.0K |
| Oct 2, 2026 | Winzeler Jeffrey G Chief Financial Officer | Sale | 284 | $20.4K |
| Oct 2, 2026 | Esaka Fumihide Chief Executive Officer | Sale | 862 | $61.9K |
| Oct 2, 2026 | Hanson Scott McLean Chief Technology Officer | Sale | 3,728 | $257.6K |
| Oct 2, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 302 | $21.7K |
| Oct 2, 2026 | Winzeler Jeffrey G Chief Financial Officer | Sale | 2,343 | $161.9K |
| Oct 2, 2026 | Winzeler Jeffrey G Chief Financial Officer | Sale | 2,828 | $197.3K |
| Sep 15, 2026 | Hanson Scott McLean Chief Technology Officer | Sale 10b5-1 plan | 100 | $6.1K |
| Sep 15, 2026 | Hanson Scott McLean Chief Technology Officer | Sale 10b5-1 plan | 1,953 | $116.3K |
| Sep 15, 2026 | Hanson Scott McLean Chief Technology Officer | Sale 10b5-1 plan | 4,947 | $299.6K |
| Sep 15, 2026 | Hanson Scott McLean Chief Technology Officer | Option exercise 10b5-1 plan | 7,000 | $56.8K |
| Sep 15, 2026 | Esaka Fumihide Chief Executive Officer | Sale 10b5-1 plan | 100 | $6.1K |
| Sep 15, 2026 | Esaka Fumihide Chief Executive Officer | Sale 10b5-1 plan | 3,785 | $225.4K |
| Sep 15, 2026 | Esaka Fumihide Chief Executive Officer | Option exercise 10b5-1 plan | 13,500 | $109.6K |
| Sep 15, 2026 | Esaka Fumihide Chief Executive Officer | Sale 10b5-1 plan | 9,615 | $582.2K |
| Sep 14, 2026 | Chen Sean Chihhsiang President and COO | Option exercise 10b5-1 plan | 15,000 | $121.8K |
| Sep 14, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 2,600 | $154.3K |
| Sep 14, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 11,000 | $662.6K |
| Sep 14, 2026 | Chen Sean Chihhsiang President and COO | Sale 10b5-1 plan | 1,400 | $85.2K |
| Sep 11, 2026 | Esaka Fumihide Chief Executive Officer | Option exercise 10b5-1 plan | 50,000 | $630.0K |
| Sep 11, 2026 | Esaka Fumihide Chief Executive Officer | Sale 10b5-1 plan | 42,083 | $2.66M |
| Sep 11, 2026 | ZHANG KER Director | Sale | 9,100 | $576.8K |
| Sep 11, 2026 | ZHANG KER Director | Sale | 900 | $57.6K |
| Sep 11, 2026 | Esaka Fumihide Chief Executive Officer | Sale 10b5-1 plan | 7,917 | $505.6K |
| Sep 4, 2026 | Chen Sean Chihhsiang President and COO | Option exercise 10b5-1 plan | 15,000 | $121.8K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Ambiq Micro, Inc.
Free account. Everything above stays public.
Write why you follow Ambiq Micro, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading